Global Cord Blood Corporation (CORBF)
OTCMKTS
· Delayed Price · Currency is USD
1.250
-0.500 (-28.57%)
Oct 28, 2024, 10:02 AM EDT
Global Cord Blood Income Statement
Financials in millions CNY. Fiscal year is April - March.
Millions CNY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '22 Mar 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | 2017 - 2013 |
| Revenue | 1,243 | 1,243 | 1,160 | 1,221 | 986.75 | 936.77 | Upgrade
|
| Revenue Growth (YoY) | 7.21% | 7.21% | -5.06% | 23.79% | 5.34% | 23.26% | Upgrade
|
| Cost of Revenue | 183.31 | 183.31 | 178.95 | 189.13 | 186.03 | 181.48 | Upgrade
|
| Gross Profit | 1,060 | 1,060 | 980.69 | 1,032 | 800.73 | 755.29 | Upgrade
|
| Selling, General & Admin | 428.79 | 428.79 | 412.05 | 452.19 | 404.38 | 462.7 | Upgrade
|
| Research & Development | 22.3 | 22.3 | 23.77 | 21.11 | 14.69 | 12.72 | Upgrade
|
| Operating Expenses | 451.08 | 451.08 | 435.82 | 473.3 | 419.07 | 475.42 | Upgrade
|
| Operating Income | 608.87 | 608.87 | 544.87 | 559.03 | 381.66 | 279.86 | Upgrade
|
| Interest Expense | - | - | - | - | - | -3.26 | Upgrade
|
| Interest & Investment Income | 33.73 | 33.73 | 32.18 | 25.87 | 26.3 | 22.57 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.64 | -0.64 | 0.16 | -0.3 | -0.06 | 0.13 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.27 | 6.27 | 8.16 | 7.39 | 5.7 | 4.23 | Upgrade
|
| EBT Excluding Unusual Items | 648.23 | 648.23 | 585.37 | 591.98 | 413.59 | 303.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | -20.39 | -20.39 | 25.39 | -13.17 | -57.13 | - | Upgrade
|
| Pretax Income | 627.84 | 627.84 | 610.75 | 578.81 | 356.46 | 303.54 | Upgrade
|
| Income Tax Expense | 118.35 | 118.35 | 94.55 | 101.08 | 61.26 | 62.66 | Upgrade
|
| Earnings From Continuing Operations | 509.48 | 509.48 | 516.21 | 477.73 | 295.2 | 240.88 | Upgrade
|
| Minority Interest in Earnings | -8.42 | -8.42 | -7.96 | -7.01 | -4.08 | -3.78 | Upgrade
|
| Net Income | 501.07 | 501.07 | 508.25 | 470.72 | 291.12 | 237.1 | Upgrade
|
| Net Income to Common | 501.07 | 501.07 | 508.25 | 470.72 | 291.12 | 237.1 | Upgrade
|
| Net Income Growth | -1.41% | -1.41% | 7.97% | 61.69% | 22.79% | 87.89% | Upgrade
|
| Shares Outstanding (Basic) | 122 | 122 | 122 | 122 | 121 | 113 | Upgrade
|
| Shares Outstanding (Diluted) | 122 | 122 | 122 | 122 | 121 | 119 | Upgrade
|
| Shares Change (YoY) | - | - | - | 0.11% | 1.75% | 63.46% | Upgrade
|
| EPS (Basic) | 4.12 | 4.12 | 4.18 | 3.87 | 2.40 | 2.10 | Upgrade
|
| EPS (Diluted) | 4.12 | 4.12 | 4.18 | 3.87 | 2.40 | 1.99 | Upgrade
|
| EPS Growth | -1.44% | -1.44% | 8.01% | 61.25% | 20.60% | 25.16% | Upgrade
|
| Free Cash Flow | 593.82 | 593.82 | 609.82 | 599.76 | 761.43 | 751.7 | Upgrade
|
| Free Cash Flow Per Share | 4.89 | 4.89 | 5.02 | 4.93 | 6.27 | 6.30 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 0.502 | Upgrade
|
| Gross Margin | 85.26% | 85.26% | 84.57% | 84.52% | 81.15% | 80.63% | Upgrade
|
| Operating Margin | 48.97% | 48.97% | 46.99% | 45.77% | 38.68% | 29.88% | Upgrade
|
| Profit Margin | 40.30% | 40.30% | 43.83% | 38.54% | 29.50% | 25.31% | Upgrade
|
| Free Cash Flow Margin | 47.76% | 47.76% | 52.59% | 49.10% | 77.17% | 80.24% | Upgrade
|
| EBITDA | 656.79 | 656.79 | 593.96 | 608.48 | 434.02 | 330.45 | Upgrade
|
| EBITDA Margin | 52.83% | 52.83% | 51.22% | 49.82% | 43.98% | 35.28% | Upgrade
|
| D&A For EBITDA | 47.92 | 47.92 | 49.09 | 49.45 | 52.37 | 50.59 | Upgrade
|
| EBIT | 608.87 | 608.87 | 544.87 | 559.03 | 381.66 | 279.86 | Upgrade
|
| EBIT Margin | 48.97% | 48.97% | 46.99% | 45.77% | 38.68% | 29.88% | Upgrade
|
| Effective Tax Rate | 18.85% | 18.85% | 15.48% | 17.46% | 17.19% | 20.64% | Upgrade
|
| Advertising Expenses | 64.92 | 64.92 | 54.44 | 49.39 | 39.59 | 37.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.